Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ASXL1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Gene Symbol | ASXL1 |
| Full Name | ASXL1 - Additional Sex Combs Like 1 |
| Chromosome | 20q11.21 |
| Protein Type | Gene |
| Function | is a critical epigenetic regulator that encodes a chromatin-binding protein involved in histone modification and transcriptional regulation. |
| Primary Expression | Corpus Callosum |
| Amino Acids | 561 aa |
| Exons | 12 |
| Pathways | Epigenetic, Immune Response, Innate Immunity, Stem Cell, inflammation |
| NCBI Gene ID | Search NCBI |
| GeneCards | ASXL1 |
| Human Protein Atlas | ASXL1 |
| Associated Diseases | Als, Alzheimer, Cancer, Cardiovascular, Heart Failure, Inflammation |
| Interactions | SF3B1, TET2, TP53, DNMT3A, U2AF1, COX6A2 |
| KG Connections | 104 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
graph TD
ASXL1["ASXL1"] -->|"involved in"| Epigenetics["Epigenetics"]
style Epigenetics fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
ASXL1["ASXL1"] -->|"regulates"| Chronic_Inflammation["Chronic Inflammation"]
style Chronic_Inflammation fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
ASXL1["ASXL1"] -->|"involved in"| Epigenetic_Regulation["Epigenetic Regulation"]
style Epigenetic_Regulation fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
ASXL1["ASXL1"] -->|"contributes to"| Clonal_Hematopoiesis["Clonal Hematopoiesis"]
style Clonal_Hematopoiesis fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
ASXL1["ASXL1"] -->|"modulates"| Inflammatory_Profile["Inflammatory Profile"]
style Inflammatory_Profile fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
ASXL1["ASXL1"] -->|"regulates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
style NEUROINFLAMMATION fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
ASXL1["ASXL1"] -->|"therapeutic target"| Cancer["Cancer"]
style Cancer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
SF3B1["SF3B1"] -->|"activates"| ASXL1["ASXL1"]
style SF3B1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
TET2["TET2"] -->|"activates"| ASXL1["ASXL1"]
style TET2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
U2AF1["U2AF1"] -->|"activates"| ASXL1["ASXL1"]
style U2AF1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
DNMT3A["DNMT3A"] -->|"activates"| ASXL1["ASXL1"]
style DNMT3A fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
GENES["GENES"] -->|"activates"| ASXL1["ASXL1"]
style GENES fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style ASXL1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Epigenetics | involved_in | process | 0.90 |
| Chronic Inflammation | regulates | process | 0.85 |
| Immune Response | regulates | process | 0.85 |
| Epigenetic Regulation | involved_in | process | 0.80 |
| Clonal Hematopoiesis | contributes_to | biological_process | 0.80 |
| Chronic Inflammation | promotes | process | 0.80 |
| Immune Responses | modifies | process | 0.80 |
| Inflammatory Profile | modulates | phenotype | 0.78 |
| inflammatory profiles | regulates | phenotype | 0.78 |
| BRAF | interacts_with | gene | 0.75 |
| NEUROINFLAMMATION | regulates | entity | 0.75 |
| Cancer | therapeutic_target | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Heart Failure | therapeutic_target | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Heart Failure | associated_with | disease | 0.65 |
| Osteoporosis | associated_with | disease | 0.65 |
| Ms | contributes_to | disease | 0.65 |
| Cardiovascular | contributes_to | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Heart Failure | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Cancer | causes | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Cardiovascular | causes | disease | 0.65 |
| SF3B1 | activates | gene | 0.60 |
| TET2 | activates | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| DNMT3A | activates | gene | 0.60 |
| U2AF1 | activates | gene | 0.60 |
| LDLR | associated_with | gene | 0.60 |
| COX6A2 | activates | gene | 0.60 |
| Rb | therapeutic_target | protein | 0.60 |
| DNMT3A | interacts_with | gene | 0.60 |
| SRSF2 | interacts_with | gene | 0.60 |
| TET2 | interacts_with | gene | 0.60 |
| DNMT3A | regulates | gene | 0.60 |
| JAK2 | regulates | gene | 0.60 |
| TET2 | regulates | gene | 0.60 |
| DNMT3A | biomarker_for | gene | 0.60 |
| TET2 | biomarker_for | gene | 0.60 |
| Epigenetic | activates | pathway | 0.60 |
| Immune Response | activates | pathway | 0.60 |
| Innate Immunity | activates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SF3B1 | activates | gene | 0.60 |
| TET2 | activates | gene | 0.60 |
| U2AF1 | activates | gene | 0.60 |
| DNMT3A | activates | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| DNMT3A | regulates | gene | 0.60 |
| TET2 | regulates | gene | 0.60 |
| LDLR | associated_with | gene | 0.60 |
| COX6A2 | activates | gene | 0.60 |
| CACNA1G | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| INFLAMMATION | causes | gene | 0.60 |
| CANCER | causes | gene | 0.60 |
| GENES | causes | gene | 0.60 |
| AND | activates | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| PPM1D | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||